Histogen, a drug development company for treatment of bacterial skin infections, has filed voluntary petitions for relief under subchapter V of Chapter 11 of the U.S. Bankruptcy Code (“Chapter 11”) in the United States Bankruptcy Court for the...
Read Story
April 19, 2024, 07:00 AM
|
LSQ originated a $25 million invoice finance facility for the U.S. operations of a global pharmaceutical manufacturer.The company was referred to LSQ by a broker partner when the client outgrew its existing line of credit with its bank partner. The...
Read Story
April 17, 2024, 07:45 AM
|
Great Rock Capital provided $33 million of capital through a senior secured credit facility to a sponsor-owned pharmaceutical manufacturing and packaging company.
The facility, which includes a revolving line of credit and a term loan, was used to...
Read Story
April 16, 2024, 08:00 AM
|
Huntington Business Credit closed a $10,000,000 new credit facility with Capital Wholesale Drug Company on January 26, 2024. Proceeds of the facility were used to refinance existing debt and provide ongoing working capital financing.Capital Wholesale...
Read Story
March 14, 2024, 07:51 AM
|
CIBC Innovation Banking provided growth financing to InsightRX, a San Francisco-based software company leveraging quantitative pharmacology and artificial intelligence (AI) to improve therapeutic decision-making from phase I drug development to the...
Read Story
February 26, 2024, 07:43 AM
|
GoodRx Holdings announced its intention to refinance its first lien credit facilities.The Company is seeking to refinance its first lien term loan facility and concurrently amend its revolving credit facility to extend the maturity date. The terms of...
Read Story
January 23, 2024, 07:27 AM
|
Journey Medical Corporation announced that the Company has entered into a credit facility with an affiliate of SWK Holdings Corporation, a specialized finance company with a focus on the global healthcare sector, providing for borrowings of up to $20...
Read Story
January 03, 2024, 07:33 AM
|
Verona Pharma plc announced it and its wholly-owned subsidiary, Verona Pharma, have entered into a debt financing facility providing the Company with access to up to $400 million from funds managed by Oxford Finance and Hercules Capital. The debt...
Read Story
January 02, 2024, 07:04 AM
|
Valeo Pharma entered into a credit facility agreement with Accord Financial for a total of $5 million.The credit facility, backed by a first-ranking lien on the company's short-term assets, carries interest at the prime rate plus an applicable margin...
Read Story
September 28, 2023, 07:36 AM
|
Mallinckrodt plc received approvals from the U.S. Bankruptcy Court for the District of Delaware for its "First Day" motions related to the Company's voluntary Chapter 11 petitions filed on August 28, 2023.As expected, the Court granted Mallinckrodt...
Read Story
August 31, 2023, 07:55 AM
|
Mallinckrodt plc, a global specialty pharmaceutical company, has taken the next step to implement the comprehensive financial restructuring plan contemplated by a Restructuring Support Agreement ("RSA") the Company previously entered into with more...
Read Story
August 28, 2023, 07:48 AM
|
HLS Therapeutics, a pharmaceutical company focusing on central nervous system and cardiovascular markets, announced an extension to its credit agreement, senior secured term loan, revolver facility and expansion facility with a syndicate of leading...
Read Story
August 14, 2023, 08:10 AM
|
Bausch Health Companies, a global diversified pharmaceutical company, and KKR announced that Bausch Receivables Funding LP, an Ontario limited partnership and wholly-owned subsidiary of Bausch Health, entered into a $600 million non-recourse...
Read Story
July 10, 2023, 08:00 AM
|
Lannett Company announced that it and certain of its subsidiaries have commenced prepackaged Chapter 11 cases in the United States Bankruptcy Court for the District of Delaware to effectuate the transactions contemplated by the Restructuring Support...
Read Story
May 03, 2023, 07:50 AM
|
Harrow, a leading U.S. eyecare pharmaceutical company, entered into a $100 million secured credit financing agreement with funds managed by Oaktree Capital Management. The interest-only secured credit facility carries an interest rate equal to the...
Read Story
March 28, 2023, 07:56 AM
|
Lighthouse Financial completed a $6 million credit facility to a Tennessee-based manufacturer and distributor of pharmaceutical products. Founded in 2001, the company markets and sells its own branded product lines of enemas, feminine hygiene...
Read Story
January 18, 2023, 07:25 AM
|
Abacus Finance Group served as Senior Secured Credit Facilities Administrative Agent and Sole Lender for senior secured credit facilities to support the leveraged buyout of Pinnacle Clinical Research, LLC by LongueVue Capital. Additionally, Abacus...
Read Story
November 28, 2022, 07:09 AM
|
Tricida entered into a debt facility with Hercules Capital. The total amount of the debt facility is $125 million of which $100 million will be available for drawdown at Tricida’s option subject to the achievement of certain milestones.Under the...
Read Story
October 20, 2022, 08:00 AM
|
HLS Therapeutics announced updates to its credit agreement and senior secured term loan with its existing syndicate of bank lenders co-led by JPMorgan Chase Bank and Silicon Valley Bank. All dollar amounts are stated in U.S. currency.The maturity...
Read Story
October 03, 2022, 07:30 AM
|
Huntington Business Credit closed a $20,000,000 new credit facility with Spirit Pharmaceuticals, LLC on July 6, 2022. Proceeds of the facility were used to refinance existing indebtedness and provide ongoing working capital growth...
Read Story
August 09, 2022, 08:06 AM
|
Hansa Biopharma AB, (Hansa), a pioneer in enzyme technology for rare immunological conditions, has entered into an agreement with U.S.-based NovaQuest Capital Management, securing $70 million in non-dilutive financing."This transaction, which extends...
Read Story
July 21, 2022, 07:45 AM
|
Click Therapeutics, a leader in Digital Therapeutics™ as prescription medical treatments, secured a $15 million term loan from Silicon Valley Bank. Proceeds from the financing were used in part to retire Click’s existing term loan facility with K2...
Read Story
April 15, 2022, 08:02 AM
|
Innocoll Biotherapeutics, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, successfully refinanced its existing term loan facility with a new $125 million term loan provided by funds managed by Oaktree Capital...
Read Story
January 31, 2022, 07:36 AM
|
Siena Healthcare Finance recently provided a $12 million working capital facility for a private equity backed, multi-state provider of specialty pharmaceutical, infusion and nutritional therapy services for patients with chronic illnesses and health...
Read Story
September 29, 2021, 07:40 AM
|
Harrow Health, an ophthalmic-focused healthcare company, and Melt Pharmaceuticals, a clinical-stage pharmaceutical company developing first-in-class medicines for sedation and analgesia, announced that Harrow Health has provided a $13.5 million...
Read Story
September 07, 2021, 07:24 AM
|
Colbeck Capital Management provided $125 million in financing to Woodward Pharma Services, LLC ("Woodward") and its affiliate Future Pak Ltd. ("Future Pak").Woodward and Future Pak, headquartered in Wixom, MI, are headed by industry veterans, David...
Read Story
August 16, 2021, 07:08 AM
|
Harmony Biosciences Holdings, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, and Blackstone entered into a strategic financing collaboration where funds managed...
Read Story
August 12, 2021, 07:06 AM
|
4D pharma plc closed a senior secured credit facility for up to $30MM with Oxford Finance LLC.“The credit facility from Oxford Finance provides access to additional capital strengthening our financial position and increasing our financial flexibility...
Read Story
July 29, 2021, 07:01 AM
|
Hilco Industrial Acquisitions, an Amsterdam-based Industrial Asset Disposition and Acquisition Company, acquired all Machinery & Equipment from the Swiss-based CMO Legacy Pharmaceuticals. After several years of expansion, the Swiss company was forced...
Read Story
April 29, 2021, 07:03 AM
|
According to an article authored by Michael Gibney, Healthcare Reporter, S&P Global Market Intelligence and published by S&P Global Market Intelligence on June 15, 2020, for some biotech and pharmaceutical companies ready to send new drugs out into...
Read Story
June 15, 2020, 09:10 AM
|
Facing nearly 2,000 lawsuits for its alleged role in facilitating America’s overdose crisis, Purdue Pharma – maker of the narcotic painkiller OxyContin – is reportedly considering filing for Chapter 11 bankruptcy, according to sources cited by...
Read Story
March 06, 2019, 08:23 AM
|
Recro Pharma, Inc., a revenue generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care settings, announced that it has closed on an amended and expanded $125 million credit facility with investment funds...
Read Story
March 04, 2019, 07:11 AM
|
Bristol-Myers Squibb Company and Burgundy Merger Sub, Inc., a wholly owned subsidiary of BMS, entered into an Agreement and Plan of Merger with Celgene Corporation (Celgene). The Merger Agreement provides, among other things, that on the terms and...
Read Story
January 04, 2019, 09:00 AM
|
ANI Pharmaceuticals, Inc. announced that it has entered an amended and restated five-year Senior Secured Credit Facility for up to $265.2 million with its existing syndicate of bank lenders. The Facility amends ANI's current $125 million Senior...
Read Story
December 28, 2018, 08:32 AM
|
Capital One announced that it served as administrative agent and lead arranger for a $350 million senior credit facility for Covis Pharma B.V. (Covis). The facility consists of a $25 million revolver and a $325 million term loan that Covis used to...
Read Story
December 13, 2018, 07:15 AM
|
Acacia Pharma Group plc, a hospital pharmaceutical company focused on the development and commercialization of new nausea & vomiting treatments for surgical and cancer patients, has secured a credit facility of up to $30 million with Hercules...
Read Story
July 02, 2018, 07:16 AM
|
pSivida Corp., a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, announced the acquisition of Icon Bioscience Inc. (Icon). Icon is a specialty biopharmaceutical company whose lead...
Read Story
April 02, 2018, 07:10 AM
|
Charles River Laboratories International, Inc. announced that it has refinanced its existing $1.0 billion of revolving credit facility due 2021 with a new $1.55 billion revolving credit facility due 2023, and its existing $650.0 million of term loan...
Read Story
March 26, 2018, 07:22 AM
|
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, announced that it has elected to file a voluntary petition under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware...
Read Story
March 12, 2018, 07:51 AM
|
Mallinckrodt has entered into a $600 million senior secured term loan facility to help finance its merger with Sucampo Pharmaceuticals, Inc., according to a regulatory filing. The New Term Loan is an incremental facility under the Credit Agreement...
Read Story
February 14, 2018, 07:15 AM
|
Super G announced the company provided a $2.0 million senior secured, interest-only bridge loan for a private equity backed, outsourced pharmaceutical service provider conducting clinical research. The senior secured, interest-only bridge loan was...
Read Story
January 25, 2018, 07:03 AM
|
Pharmaceutical Research Associates, Inc., a Virginia corporation (PRA) and a wholly-owned subsidiary of PRA Health Sciences, Inc., entered into a First Amendment and Second Joinder Agreement to the Credit Agreement, dated as of December 6, 2016 with...
Read Story
January 02, 2018, 07:00 AM
|
Recro Pharma, Inc., a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, announced that it has secured a $100 million credit facility from funds managed by Athyrium Capital...
Read Story
November 21, 2017, 07:09 AM
|
Emergent BioSolutions Inc. announced that it has completed a new five-year, $200 million syndicated senior secured credit facility. This new facility replaces and represents an increase from the company's prior $100 million facility, which was...
Read Story
October 02, 2017, 08:00 AM
|
Teva Pharmaceutical Industries Ltd., announced amendments to its USD and JPY term loan and revolving credit facilities, providing Teva greater flexibility in its financial leverage ratio covenants. The amended leverage ratio covenants in the credit...
Read Story
September 20, 2017, 07:10 AM
|
Synergy Pharmaceuticals Inc. announced that the company has closed on a $300 million debt financing structured as senior secured loans from CRG LP, a healthcare focused investment firm, and its lender syndicate.“This non-dilutive financing enhances...
Read Story
September 06, 2017, 07:09 AM
|
Heska Corporation announced that it has entered into a new $30 million credit agreement with JPMorgan Chase, Inc. The credit agreement matures in July 2020 and replaces the Company's existing $15 million asset based line of credit. The new facility...
Read Story
July 28, 2017, 07:08 AM
|
Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, announced that it has entered into a $50 million senior...
Read Story
July 17, 2017, 07:17 AM
|